戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 CS gene is associated with susceptibility to invasive pulmonary aspergillosis.
2  genome was associated with the incidence of invasive pulmonary aspergillosis.
3 ial association between severe influenza and invasive pulmonary aspergillosis.
4 nditions and in a neutropenic mouse model of invasive pulmonary aspergillosis.
5  possible, and the remaining 165 patients no invasive pulmonary aspergillosis.
6 drugs, and is avirulent in a murine model of invasive pulmonary aspergillosis.
7 ematopoietic cell transplant recipients with invasive pulmonary aspergillosis.
8 y avirulent in two distinct murine models of invasive pulmonary aspergillosis.
9 e models of haematogenously disseminated and invasive pulmonary aspergillosis.
10 us infection in vitro and in mouse models of invasive pulmonary aspergillosis.
11 yene may be antagonistic in the treatment of invasive pulmonary aspergillosis.
12 ions of lung tissue recovered from mice with invasive pulmonary aspergillosis.
13 nd increases susceptibility to postinfluenza invasive pulmonary aspergillosis.
14 istance of A. terreus to AmB in experimental invasive pulmonary aspergillosis.
15 ay represent a new strategy for treatment of invasive pulmonary aspergillosis.
16 id-treated animals against subsequent lethal invasive pulmonary aspergillosis.
17 ha is an important proximal signal in murine invasive pulmonary aspergillosis.
18 ction in an immunosuppressed murine model of invasive pulmonary aspergillosis.
19 d rescued influenza virus-infected mice from invasive pulmonary aspergillosis.
20 tal cohort (n = 524), 79 patients had proven invasive pulmonary aspergillosis (15.1%).
21  cohort of critically ill patients, putative invasive pulmonary aspergillosis according to AspICU alg
22  In this study we evaluated the incidence of invasive pulmonary aspergillosis among intubated patient
23                We evaluated the incidence of invasive pulmonary aspergillosis among intubated patient
24                                Incidences of invasive pulmonary aspergillosis, an infection caused pr
25 p. was recovered as the etiological agent of invasive pulmonary aspergillosis and had reduced in vitr
26  are unexplored targets for the treatment of invasive pulmonary aspergillosis and may potentiate both
27               In noncancer populations, both invasive pulmonary aspergillosis and mucormycosis are as
28    Little is known about the pathogenesis of invasive pulmonary aspergillosis and the relationship be
29 idence that the inflammatory response during invasive pulmonary aspergillosis, and in particular the
30                This is particularly true for invasive pulmonary aspergillosis, as so far, sources of
31  depletion of neutrophils, animals developed invasive pulmonary aspergillosis, associated with delaye
32 1.9%) were diagnosed with putative or proven invasive pulmonary aspergillosis, based on the validated
33          Reaching a consensual definition of invasive pulmonary aspergillosis becomes mandatory and c
34                   The increased incidence of invasive pulmonary aspergillosis, caused by Aspergillus
35                                              Invasive pulmonary aspergillosis causes substantial mort
36 pulmonary aspergillosis, two each with acute invasive pulmonary aspergillosis, chronic necrotizing pu
37                              From 2014-2019, invasive pulmonary aspergillosis complicated 7.2% (0-23.
38 CalA antibody improves survival of mice with invasive pulmonary aspergillosis, demonstrating the pote
39                        Conclusions: A proven invasive pulmonary aspergillosis diagnosis was found reg
40                                           In invasive pulmonary aspergillosis, direct invasion and oc
41                                   Rationale: Invasive pulmonary aspergillosis has emerged as a freque
42 inophil recruitment in neutropenic mice with invasive pulmonary aspergillosis (IA).
43 ant opportunistic fungal pathogen and causes invasive pulmonary aspergillosis in conditions with comp
44                         By use of a model of invasive pulmonary aspergillosis in corticosteroid-treat
45 ergillus respiratory tract colonization from invasive pulmonary aspergillosis in critically ill patie
46 s fumigatus is an important pathogen causing invasive pulmonary aspergillosis in immunocompromised pa
47 nhanced fungal clearance during experimental invasive pulmonary aspergillosis in neutropenic mice.
48 le in simultaneous treatment of experimental invasive pulmonary aspergillosis in persistently neutrop
49 nd-generation triazole, against experimental invasive pulmonary aspergillosis in persistently neutrop
50 inate Aspergillus colonization from putative invasive pulmonary aspergillosis in this patient group.
51 ) is an uncommon but severe clinical form of invasive pulmonary aspergillosis in which the fungal inf
52  relevant literature related to diagnosis of invasive pulmonary aspergillosis, invasive candidiasis,
53                             Risk factors for invasive pulmonary aspergillosis (IPA) after kidney tran
54 e prognostic factors and optimal therapy for invasive pulmonary aspergillosis (IPA) after kidney tran
55 eolar lavage (BAL) fluid in the diagnosis of invasive pulmonary aspergillosis (IPA) among solid-organ
56 te clinical setting, is highly suggestive of invasive pulmonary aspergillosis (IPA) and associated wi
57 eloid leukemia during the study period, with invasive pulmonary aspergillosis (IPA) complicating 6.8%
58 f antifungal therapy on an LFD developed for invasive pulmonary aspergillosis (IPA) detection.
59                                              Invasive pulmonary aspergillosis (IPA) has dire conseque
60                                   Diagnosing invasive pulmonary aspergillosis (IPA) in non-immunosupp
61                                              Invasive pulmonary aspergillosis (IPA) is a frequently f
62                                              Invasive pulmonary aspergillosis (IPA) is a life-threate
63                                              Invasive pulmonary aspergillosis (IPA) is a life-threate
64                                              Invasive pulmonary aspergillosis (IPA) is a life-threate
65                                              Invasive pulmonary aspergillosis (IPA) is a significant
66                                              Invasive pulmonary aspergillosis (IPA) is a significant
67 damage due to unresolved inflammation during invasive pulmonary aspergillosis (IPA) is associated wit
68                                              Invasive pulmonary aspergillosis (IPA) is frequent and o
69                                              Invasive pulmonary aspergillosis (IPA) is often a lethal
70                                              Invasive pulmonary aspergillosis (IPA) is one of the maj
71  identification of the causative organism in invasive pulmonary aspergillosis (IPA) is recommended.
72                                              Invasive pulmonary aspergillosis (IPA) is the most commo
73                                 Diagnosis of invasive pulmonary aspergillosis (IPA) remains a major c
74                                              Invasive pulmonary aspergillosis (IPA) remains an import
75 topoietic stem cell transplant recipients to invasive pulmonary aspergillosis (IPA), as correct level
76                                              Invasive pulmonary aspergillosis (IPA), once limited to
77 hogens, including 20 with probable or proven invasive pulmonary aspergillosis (IPA), seven with mucor
78 ion plays a major role in the development of invasive pulmonary aspergillosis (IPA).
79 ught to contribute to therapeutic failure in invasive pulmonary aspergillosis (IPA).
80 idered the gold standard test for diagnosing invasive pulmonary aspergillosis (IPA).
81  of Axl in antifungal immunity in a model of invasive pulmonary aspergillosis (IPA).
82 e is a first-line agent for the treatment of invasive pulmonary aspergillosis (IPA).
83 amples may facilitate the early diagnosis of invasive pulmonary aspergillosis (IPA).
84 ed for evaluation of patients with suspected invasive pulmonary aspergillosis (IPA).
85 pharmacodynamics of caspofungin (CAS) during invasive pulmonary aspergillosis (IPA).
86 mpromised patients, typically manifesting as invasive pulmonary aspergillosis (IPA).
87                                              Invasive pulmonary aspergillosis is a common and devasta
88                                              Invasive pulmonary aspergillosis is a devastating compli
89                                              Invasive pulmonary aspergillosis is a devastating compli
90                                              Invasive pulmonary aspergillosis is a leading cause of i
91                                              Invasive pulmonary Aspergillosis is a leading cause of m
92                                              Invasive pulmonary aspergillosis is acquired through inh
93                                              Invasive pulmonary aspergillosis is an emerging devastat
94                                              Invasive pulmonary aspergillosis is an important cause o
95 influx of mononuclear cells into the lung in invasive pulmonary aspergillosis is in part mediated by
96 l effectors, and antifungal drug therapy for invasive pulmonary aspergillosis may be further understo
97 burden, and in situ angiogenesis in a murine invasive pulmonary aspergillosis model.
98  death protein 1 (PD-1) blockade in a murine invasive pulmonary aspergillosis model.
99 ppo-silenced mutant was hypervirulent in the invasive pulmonary aspergillosis murine model system and
100 ion in fungal lung burdens in a rat model of invasive pulmonary aspergillosis (p<0.05) compared to tr
101  Moreover, in a separate cohort of confirmed invasive pulmonary aspergillosis patients, polymorphisms
102 he new definition was compared with putative invasive pulmonary aspergillosis (PIPA).
103   First, in patients with proven or probable invasive pulmonary aspergillosis, should combination the
104   First, in patients with proven or probable invasive pulmonary aspergillosis, should combination the
105 e is unlikely to serve as an S source during invasive pulmonary aspergillosis since a sulfate transpo
106 illosis, the role of PCR in the diagnosis of invasive pulmonary aspergillosis, the role of beta-d-glu
107 ng in serum and BAL and for the diagnosis of invasive pulmonary aspergillosis, the role of PCR in the
108 se damage is associated with poor outcome to invasive pulmonary aspergillosis, this suggested that IF
109 as made for patients with proven or probable invasive pulmonary aspergillosis to receive either initi
110 as made for patients with proven or probable invasive pulmonary aspergillosis to receive either initi
111                                              Invasive pulmonary aspergillosis was an independent risk
112                                              Invasive pulmonary aspergillosis was defined according t
113                           Probable or proven invasive pulmonary aspergillosis was diagnosed in 14% of
114 us is an environmental fungus that can cause invasive pulmonary aspergillosis when spores are inhaled
115 evere respiratory disease, and postinfluenza invasive pulmonary aspergillosis, which is becoming a we
116 articipants underwent screening protocol for invasive pulmonary aspergillosis with bronchoalveolar la
117 ticipants underwent a screening protocol for invasive pulmonary aspergillosis with bronchoalveolar la
118 an and 1,3-beta-d-glucan concentrations than invasive pulmonary aspergillosis without tracheobronchia

 
Page Top